Información del producto
Gdc-0152 is a small molecule drug that inhibits the polymerase chain reaction (PCR) by binding to the enzyme DNA polymerase. Gdc-0152 targets human cells, inhibiting growth in tumor cell lines and in patients with bone cancer. It has been shown to suppress autophagy, which may have therapeutic benefits for cancer treatment. Gdc-0152 has also been shown to inhibit survivin, a protein that can stimulate tumor growth and metastasis. Gdc-0152 is currently being developed as an anticancer drug for use in humans.
Propiedades químicas
Consulta técnica sobre: 3D-FC178731 Gdc-0152
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
